Search - tctmd.com

Displaying 241 - 260 of 864

Sort: Relevancy | Date

Presentation ACC 2024

Percutaneous Transvalvular Micro axial Flow Pump in Infarct Related Cardiogenic Shock

Presenter: Jacob Eifer Møller

April 07, 2024

Presentation THT 2024

Shock-Phenotype Matching Using Real-World Evidence: A New Paradigm for Prospective Enrollment in Clinical Trials of Acute MCS Devices in Cardiogenic Shock

Presenter: James W. Schurr

March 06, 2024

Presentation THT 2024

DPP3-Based Biotherapy in Cardiogenic Shock

Presenter: Mahir Karakas

March 06, 2024

Presentation THT 2024

Ivabridine in Cardiogenic Shock

Presenter: Maya Guglin

March 06, 2024

Presentation THT 2024

The Conundrum of Clinical Trials in Cardiogenic Shock

Presenter: JoAnn Lindenfeld

March 06, 2024

Presentation THT 2024

The RECOVER IV Study Overview

Presenter: Navin K. Kapur

March 05, 2024

Presentation THT 2024

Pulmonary Artery Catheter in Shock (PACCS)

Presenter: Shashank Shekhar Sinha

March 05, 2024

Presentation THT 2024

ECMO-Unload: Is This the Answer to ECLS-SHOCK?

Presenter: Dirk Westermann

March 05, 2024

Presentation THT 2024

DoReMe: Are Inotropes Helpful or Harmful?

Presenter: Benjamin Hibbert

March 05, 2024

Presentation THT Abstracts 2024

Outcomes of Impella 5.5 in Heart Failure-Related Cardiogenic Shock from the SURPASS (Surgical Unloading Renal Protection and Sustainable Support) Registry

Presenter: Jacob Abraham

March 05, 2024

Presentation THT Abstracts 2024

Clinical Outcomes and the Impact of SCAI Stage among ProtekDuo Right Ventricular Assist Device Recipients with Cardiogenic Shock: A Report from the Cardiogenic Shock Working Group

Presenter: Kevin John

March 05, 2024

Presentation THT Abstracts 2024

Clinical Outcomes and Adverse Events in Cardiogenic Shock Patients who Recieved Impella 5.0/5.5: A Report from the Cardiogenic Shock Working Group

Presenter: Justin Fried

March 05, 2024

Presentation THT Abstracts 2024

Percutaneous VA-ECMO during TAVI in Patients with Cardiogenic Shock and Severely Depressed Left Ventricular Function

Presenter: Eduardo Arias

March 05, 2024

Presentation THT Abstracts 2024

Predictors of Acute Limb Ischemia in Cardiogenic Shock patients on Mechanical Circulatory Support

Presenter: Kevin John

March 05, 2024

Presentation THT Abstracts 2024

Sex Differences in Acute Heart Failure Related Cardiogenic Shock

Presenter: Rebecca Smoller

March 05, 2024

Presentation THT Abstracts 2024

Newly Developed Cardiogenic Shock Team: 10 month update

Presenter: Robin Miller

March 05, 2024

Presentation THT Abstracts 2024

Cardiogenic Shock in the Community 2013 Outcomes of Cardiogenic Shock at a tertiary, non-durable VAD, non-transplant care center†

Presenter: Chirag Mehta

March 05, 2024

Presentation THT Abstracts 2024

Percutaneous Axillary Intra-aortic Balloon Pumps for Cardiogenic Shock Due to Acute Decompensated Heart Failure as a Bridge to Ambulation and Heart Transplant

Presenter: Justin Cortez

March 05, 2024

Presentation THT Abstracts 2024

A Report from the Cardiogenic Shock Working Group on use of Impella 5.0/5.5 for Cardiogenic Shock and Successful Bridge to Recovery, durable LVAD or Heart Transplantation

Presenter: Maryjane Farr

March 05, 2024

Presentation THT 2024

Inotropes and Mortality in Patients With Cardiogenic Shock Due to Myocardial Infarction: Insights from the SWEDEHEART Registry

Presenter: Elmir Omerovic

March 05, 2024

Advertisement

Percutaneous Transvalvular Micro axial Flow Pump in Infarct Related Cardiogenic Shock

Shock-Phenotype Matching Using Real-World Evidence: A New Paradigm for Prospective Enrollment in Clinical Trials of Acute MCS Devices in Cardiogenic Shock

DPP3-Based Biotherapy in Cardiogenic Shock

Ivabridine in Cardiogenic Shock

The Conundrum of Clinical Trials in Cardiogenic Shock

The RECOVER IV Study Overview

Pulmonary Artery Catheter in Shock (PACCS)

ECMO-Unload: Is This the Answer to ECLS-SHOCK?

DoReMe: Are Inotropes Helpful or Harmful?

Outcomes of Impella 5.5 in Heart Failure-Related Cardiogenic Shock from the SURPASS (Surgical Unloading Renal Protection and Sustainable Support) Registry

Clinical Outcomes and the Impact of SCAI Stage among ProtekDuo Right Ventricular Assist Device Recipients with Cardiogenic Shock: A Report from the Cardiogenic Shock Working Group

Clinical Outcomes and Adverse Events in Cardiogenic Shock Patients who Recieved Impella 5.0/5.5: A Report from the Cardiogenic Shock Working Group

Percutaneous VA-ECMO during TAVI in Patients with Cardiogenic Shock and Severely Depressed Left Ventricular Function

Predictors of Acute Limb Ischemia in Cardiogenic Shock patients on Mechanical Circulatory Support

Sex Differences in Acute Heart Failure Related Cardiogenic Shock

Newly Developed Cardiogenic Shock Team: 10 month update

Cardiogenic Shock in the Community 2013 Outcomes of Cardiogenic Shock at a tertiary, non-durable VAD, non-transplant care center†

Percutaneous Axillary Intra-aortic Balloon Pumps for Cardiogenic Shock Due to Acute Decompensated Heart Failure as a Bridge to Ambulation and Heart Transplant

A Report from the Cardiogenic Shock Working Group on use of Impella 5.0/5.5 for Cardiogenic Shock and Successful Bridge to Recovery, durable LVAD or Heart Transplantation

Inotropes and Mortality in Patients With Cardiogenic Shock Due to Myocardial Infarction: Insights from the SWEDEHEART Registry

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content